𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Acyclovir influence on graft versus host disease

✍ Scribed by Dr. R. Saral


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
802 KB
Volume
41
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Memory lapses in graft-versus-host disea
✍ Barry Flutter; Pedro VeliΓ§a; Ronjon Chakraverty πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 199 KB πŸ‘ 1 views
Pathophysiology of acute graft-versus-ho
✍ Pavan Reddy πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 175 KB

Graft-versus-host disease (GVHD) has been the primary limitation to the wider application of allogeneic bone marrow transplantation (BMT). The pathophysiology of acute GVHD is complex and can be conceptualized to be a three-step process based on murine studies. In step 1, the conditioning regimen le

Influence of the length of the small bow
✍ Jacques Pirenne; Milbhor D'Silva; Etienne Hamoir; Frederic Lardinois; Viviana Fr πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 488 KB πŸ‘ 1 views

## Abstract The influence of the length and origin of a small bowel graft on graft versus host disease (GVHD) was studied in 33 (Lewis Γ— brown Norway) F1 hybrids transplanted with different types of Lewis small bowel grafts. Recipients of an entire small bowel graft (N = 9), a jejunal graft (N = 6)

Hyperacute graft-versus-host disease and
✍ Tanaka, Y.; Kami, M.; Ogawa, S.; Machida, U.; Takahashi, T.; Ichikawa, M.; Yuji, πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 105 KB πŸ‘ 2 views

## Disseminated Histoplasmosis Following Prolonged Low-Dose Methotrexate Therapy To the Editor: A 43-year-old woman from central Minnesota presented to her primary internist with a 4-month history of weight loss and abdominal distension and a 2-week history of fevers, sweats, weakness, and anorexia

Extracorporeal photopheresis in children
✍ Ka Wah Chan πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 80 KB

## Abstract Acute and chronic graft‐versus‐host disease (GVHD) are major complications after allogeneic hematopoietic stem cell transplantation. Systemic corticosteroid is the first line of therapy but only half of the patients will respond. The management of steroid‐refractory or steroid‐dependent